The National Osteoporosis Foundation has named leading rheumatologist Ken Saag from UAB as president of the group’s Board of Trustees.
UAB has implemented a new application suite to improve clinical trial management, and enhance communication among trial sites and with study participants.
A quality-control checkpoint in pre-B cells restricts the range of antibodies produced by mature B cells, and manipulation of the checkpoint could make vaccines more potent.
UAB researchers will use a $1.8 million grant to look at single cells for altered expression of the interferon gamma receptor gene.
UAB’s new REACT Center is the national coordinating center for six centers designed to promote research and train scientists and clinicians in the medical rehabilitation field.
Part of the challenge is to do a better job of helping patients make their own, well-informed choices.
Two prominent faculty members from the UAB Department of Medicine have been elected to become members of the American Society for Clinical Investigation (ASCI).
Recognition of a new pathway may change the treatment of allergic diseases.
UAB is using an online survey to learn more about the relationship between diet and gout.
UAB leads a team that crafts new American College of Rheumatology guidelines for 2015 on treatment of rheumatoid arthritis.